Just noticed crack spread above USD 9! Hengyuan need USD 4 crack spread to breakeven cost. Anything above cost is PURE profit margin alrdy

Recent private placement at 47.5sen already raise up RM 130m, together with recent director share option exercise price for 53.8sen raise fund RM 38m, total fresh fund raise now RM 168m.


1. Coal power (1200MW) - completed and fully COD in Jan 2021. The profit generated will accumulated for Jaks to subscribed additional 10% equity from 30% stake to 40%. Therefore, no further is needed

2. Solar power (50MW) need RM 50m equity capital + concession back debt - RM 50m already fully equip now and awaiting former PPA signing with Tenaga by Aug 2021.

3. Hydropower and additional solar power in Sabah - Balance fresh capital RM 118m is ready to fund equity portion for any new Power plant later.

Thus, Jaks now is in much better position to bid more power plant.

Jaks is on right path to concentrate on power generation concession business model now, ensure steady long term profit over 25 year (coal power), 21 year (solar power) and potential next hydropwer (25-30 year)

Current price 46.5sen is even lower than recent private placement 47.5sen to develop solar power plant (50MW).

1. Coal fire power 1200 MW (30-40% ownership)
2. Solar power 50 MW (100% own)
3. hydropower ? (JV with Sabah gov)

Add all margin line to maybulk at 76-77sen

Agreed, political sentiment is a risk, but what could be worse than current political rulling now. The worse is alrdy now, election is ultimately solution to current tussle, to settle current worse politic.

Steel company still open for business, but operate below capacity. Hiaptek hardware trading still able to operate 60% capacity.

Steel price is global commodity, most of the global country are aim for recovery post pandemic. Recovery need steel to build infrastructure to spur economy. The real demand of steel is just started in China as it alrdy in post pandemic stage, the next steel demand will come from any other country on top of China, such as US infrastructure project which just pass the budget, European region and Asia will be next demand growth post pandemic

I expect just need to wait for 2-3 month. Market alway look forward 3 to 6 month. The reason why hiaptek sold down despite good result is negative impact MCO will affect next Q result. But, after 3 month, MCO will move to next phase and vaccination rate to hit 40%, it will likely in next Q result pose lower profit but comment recovery in following Q due to lifted MCO impact.

Director warrant conversion at 50sen now is timely to raise fresh capital for expansion.

As long as return of these new equity is higher than cash, it is earning accretive instead of dilution.

MCO affect all manufacturers, market will eventually look beyond these temporary setback.

Recovery theme will resume once vaccination rate hit 10% in mid July and moving to second phase, then vaccination rate next 40% in Aug - Sept, moving to next phase

The Confirmation is that vaccination rate will definitely increase toward next 1 - 2 month

Director excerise price warrant at 50sen

Bought all hiaptek at 51.5sen

Locked all profit in kpower, but offset partially by loss incur in serbak.

Sold all serbak at 32.5sen

Sold all kpower at 67-67.5sen,

Once share rebound, all yesterday negative comment will disappear.

Today will appoint 5 new ID.

Once SD meet EPF request, selling will ease off. Hold for betterment outcome soon.

EPF will protect stake holder interest albeit it also force to cut stake. EPF urge SD to appoint new auditor and new ID to resolve issue.

The down pressure is easing ahead of new appointment soon

EPF today urge SD to expedite appointments auditor and new ID to resolve issue.

Current price 65sen, kpower have limited downside risk alrdy, back by solar business, net cash and dividend payout.

Kpower is dividend yield stock

Kpower is in booming solar business

Kpower is in NETCASH position.

The main sold off pressure in thses 2 day from 50sen are due to quit ID and quit KPMG.

Therefore, it is common understanding that if SD appoint new EY and new ID, share price should back to above 50sen.

Director selling Kpower FREE wrrant to monetize and profiting these out of money free warran, but keep hold on underlying kpower share and all its retain stake holding.

Kpower with up Power as soon as SD appoint EY confirmed

As soon as confirmation new appointment release, share price will Strongly rebound. Current price already BOTTOM

Further downside risk very limited, just need to await confirmation new appointment EY.

Use margin line, bought all SD at 34.5sen

If SD appoint EY confirm, share will rebound STRONGLY

Despite affected by SD on the ground that that share common major shareholder, but, kpower fundamentally is good in view of bright business in solar power.

Risk price in. Share hit bottom, rebound is expectef

All in kpower

Bought all kpower at 64sen

Serbak now is facing issue to appoint new independent director as any new appointee ia at risk of blame by all authorities and public as preceived agree to current CEO to sue KPMG. No one dare to accept appointments, fear of loss reputation

Despite posted good result with too good to be profit margin and several private placement to increase share capital, raise up to RM 1 billion cash, BUT

1. Outstanding Receveible increase
2. Loan and borrowing increase
3. Cash decrease

EPF acting too slow to dispose share.... Affecting all MALAYSIAN CONTRIBUTOR.

Glove share price is now facing downtrend in tandem with global vaccination rate with limit down ahead, pending to WHO official announment on end of pandemic by year end or early next year.

Prepandemuc - glove global demand on steady 12% annual growth
Glove maker increase capacity 10-15% to meet normal. Growth demand

Pandemic - Acute shortage of glove as global demand soar to 20- 25% growth
Glove maker and new comer plan 100% capacity within 2 year time with 40% on staggering operation follow by another 60%, resulted lead time reduce and increase supply for spot order

Post pandemic - still elevated demand for glove, 15% annual growth
Glove maker 40-100% increase new capacity will flush global market leading to global over supply, intense competition from new comer to grab market share and triple capacity increasement from china glove maker will erode Malaysia global market share

Acute demand will ease post pandemic + double up capacity by exiting glove maker in Malaysia + new capacity from new comer + triple up capacity from China = stiff competition = ASP toward pre pandemic or even lower dur to OVER SUPPLY

Dividend 30% payout is coming

Private placement - - - > negative to warrant holder due to

1. Warrant exercise price - unchanged
2. Warrant lifespan - unchanged
3. Dilutive to underlying share earning and share price lead to increase risk of unexercieable out of money warrant

The middleman is pharmaniaga. Why need to waste time to allow pharmaniaga to set up processing vaccine plant in Malaysia which only transfer vaccine in bulk from China, bottle vaccine in Malaysia!?

These is typical middleman business just like proton import CKD car from. China, assembly locally. However, Vaccine is in urgent need, wasting time soley just for pharmaniaga to profit is evil motive

At IPO price of RM4.55 per FGV Share and now being offered to be acquired
at RM1.30 per FGV Share, and taking into consideration of the significant
improvement on the quality of plantation assets of FGV since IPO, the director are UNABLE to, with clear conscience recommend the Offer as REASONABLE to the minority shareholders of FGV, which also include settlers and employees of FELDA and FGV respectively.

The improvements made on the quality of plantation assets include amongst others,
improvements to the average age profile from 16.25 years in 2012 to 13.77
years in 2019 through aggressive replanting efforts, incurring approximately
RM5.3 billion since 2012 to cover replanting costs, improvements on housing
for workers, and fertiliser costs, as well as increased landbank size since IPO
from 382,603 hectares to 439,230 hectares in 2019.

Stay close and defend FGV from delisting which is nonetheless IMPOSSIBKE now as felda only able to left 1 FINAl day before lapse on next Monday. The total stake is still far far below threshold 90%, up to date only about 74%, which will not only definitely remain listed, but also capable compliance bursa listing on 25% public spread.

If current CPO able to maintain at elevated level for prolong time at least RM 3000 above, FGV forward earning will keep improving, likely surpass its earning before its IPO RM 4.55 in 2012

Felda cannot buy anything above 1.30, if it did, all the accepted earlier offer price at 1.30 have to raise up.

Thetefore, felda cannot buy anymore fgv share at 1.30 as almost all today transaction price is done at 1.31-1.32.

Those buy above 1.30 is to ensure felda cannot delist fgv share by prevent felda to accumulate stake to above 90%.

Just few day more, felda will officially annouce take over failed. Shareholder will continue hold fgv share and entitle 3 sen dividend and enjoy much higher updide as CPO price now is above RM 4000, fgv is largest palm oil planter and sugar, both business will continue shine, fgv willreap much higher profit. As free open market supply share is limited now, share price will easily uptrend.

FGV declared 3sen dividend, but the ex-date is 2 day after final take over lapse. FGV unlikely to success delist FGV as it stake is still far far below threshold 90% stake.

Thus, those opt to retain their holding can continue keep fgv after final offer lapse and entitle 3 sen dividend and more upside potential.

bought maximum cypark at 1.41-1.45

bought samaiden at 1.70-1.74

cut all ataims at 2.73-2.74